NSC |
Compound |
Enrichment |
Correlation |
NSC 670803 |
1-Octene, 3-(bromomethyl)-2,3,7-trichloro-7-methyl- |
0.035202825328704 |
-0.26539144 |
NSC 673499 |
Null |
0.035202825328704 |
0.21207997 |
NSC 679024 |
1,8-Naphthyridin-4(1H)-one, 2-(4-fluorophenyl)-5-methyl- |
0.035202825328704 |
0.20118949 |
NSC 718781 |
Erlotinib hydrochloride |
0.0352028253287042 |
-0.21014644 |
NSC 724783 |
[1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 |
0.0352028253287042 |
-0.14855304 |
NSC 726217 |
Combretastatin A4-analogue |
0.0352028253287042 |
0.050493899 |
NSC 726442 |
4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride |
0.0352028253287042 |
0.10086048 |
NSC 726578 |
Null |
0.0352028253287042 |
0.24268842 |
NSC 727620 |
6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride |
0.0352028253287042 |
-0.012804772 |
NSC 732205 |
Null |
0.0352028253287042 |
0.16393755 |